Necsa earns millions in international nuclear exports
Date: 11 October 2016
The South African Nuclear Energy Corporation (Necsa) has been paid the first R1.7 million of a fabrication contract to manufacture nuclear reactor components for Russia.
The first items fabricated at the Pelindaba site of Necsa, outside Pretoria have been delivered to the Russian Company Tenex, which is subsidiary of the Russian nuclear power company Rosatom.
The first payment represents about a quarter to a third of the total contract.
The Chairman of Necsa, Dr Kelvin Kemm said “I am pleased and proud of the fact that Necsa continues to fabricate and export nuclear assemblies internationally.” He added; “We are pleased to be able to build on the nuclear technology exchange agreements which have been signed with Russian nuclear companies.”
The CEO of Necsa, Mr Phumzile Tshelane, was upbeat about the development and said: “Necsa is the only company in South Africa currently internationally licensed to manufacture components to nuclear grade standards for nuclear reactor applications.”
He expressed his confidence in local ability and said: “I know that there are many South African companies, large and small, which have facilities and systems operating at or near nuclear grade standard. Necsa is keen to work with them to expand South Africa’s nuclear fabrication capabilities to optimize our benefit from the major new nuclear build opportunities which are around the corner.”
Under the US ASME system of international quality standards, Necsa is certified to design and manufacture components and assemblies for international nuclear applications. Systems such as ASME are internationally accepted as proof of the quality standard as required for nuclear applications.
Tshelane said: “It was a long hard road to get the N-Stamp or ASME certification for both design and manufacture but it has been worth it. I want to congratulate the Necsa technical staff who shows such pride and dedication in their work. Without such an attitude world class work is not possible.”
Necsa is currently the second largest shareholder in the world in the international market for nuclear medicine. Necsa exports nuclear medicine to some 60 countries.
Nuclear medicine intentionally has a short shelf life of about a week, so a very important factor in its export is the efficiency of an effective high speed international distribution system.
Nikelwa Tengimfene Necsa Chairman Office:
Senior Manager: Stakeholder Relations
Tel: +27-12-305-5458 Carol van Niekerk
Fax: +27-12-305-0000 (012) 807 3920
Cell: +27-82-574-5495 E-mail: email@example.com